[Measurement of treatment efficacy in diabetes: effect of atherosclerosis prevention and general effects].
Numerous indirect and direct, long-term, well designate, multicenter studies are pointing to the fact, that intensification of the hypoglycemic therapy of diabetes mellitus and also the control of the non-hyperglycemic risk factors of atherosclerosis decrease the incidence, morbidity and mortality due to atherosclerosis complications in the subpopulation of diabetics type I as well as type II. This positive finding requires the objective monitoring of the quality of diabetes mellitus care. One has to be sure, that its activity exerts also the anti-atherogenic effect. The respective indices are presented using the suggestions of the experts committees of the European Association for the Study of Diabetes (EASD).
Czech
A
A
Katedry i Kliniki Chorób Wewnetrznych i Diabetologii Akademii Medycznej w Warszawie.
Szczeklik-Kumala
Z
Z
D000293:Adolescent; D000328:Adult; D000368:Aged; D001161:Arteriosclerosis / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D002648:Child; D002784:Cholesterol / Q000097:blood; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000628:therapy*; D003925:Diabetic Angiopathies / Q000097:blood / Q000517:prevention & control*; D006801:Humans; D008055:Lipids / Q000097:blood; D008875:Middle Aged; D008991:Monitoring, Physiologic
D008055:Lipids; D002784:Cholesterol